Bioventix plc (BVXP) Ordinary 5p
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Director dealings: Bioventix CFO raises stake
31 October 2024 15:15
(Sharecast News) - Bioventix revealed on Thursday that chief financial officer Bruce Hiscock had acquired 333 ordinary shares in the London-listed antibodies development and supply company.
-
BioVentix reports year of growth, warns of geopolitical risks
28 October 2024 09:32
(Sharecast News) - BioVentix, a UK-based developer of high-affinity monoclonal antibodies for clinical diagnostics, reported a 6% improvement in full-year revenue on Monday, to £13.6m, up from £12.82m in...
-
BioVentix revenue, earnings rise in first half
25 March 2024 12:17
(Sharecast News) - Monoclonal antibody specialist BioVentix reported a 13% rise in first-half revenue on Monday, to £6.7m, compared to £5.9m in the prior year.
-
Sunday share tips: Octopus Renewables Infrastructure Trust, Bioventix
19 November 2023 21:24
(Sharecast News) - The Financial Mail on Sunday's Midas column tipped the Octopus Renewables Infrastructure Trust to readers, pointing out its 7% dividend yield and the current valuation of its shares.
-
BioVentix revenue, profits improve in full-year results
24 October 2022 11:55
(Sharecast News) - Diagnostic monoclonal antibody specialist BioVentix reported a 7% improvement in revenue in its full-year results on Monday, to £11.72m.
-
Bioventix hikes interim dividend after revenue falls
28 March 2022 11:48
(Sharecast News) - Monoclonal antibody developer and supplier Bioventix reported an 8% fall in revenue in its first half on Monday, to £4.7m.
Company announcements Announcements
-
Notice of AGM
8 November 2024 07:57
Bioventix
-
Director/PDMR Shareholding
31 October 2024 07:00
Bioventix
-
Results for the year ended 30 June 2024
28 October 2024 07:00
Bioventix
-
Holding(s) in Company
25 October 2024 10:37
Bioventix
-
Holding(s) in Company
16 October 2024 13:51
Schroders
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.